Black Rock Inc. Apellis Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,795,272 shares of APLS stock, worth $112 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,795,272

Previous 5,494,591 5.47%

Holding current value

$112 Million

Previous $323 Million 31.17%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$38.07 - $59.71 $11.4 Million - $18 Million	300,681 Added 5.47%	5,795,272 $222 Million
Q1 2024 May 10, 2024	BUY	$55.39 - $72.47 $6.28 Million - $8.21 Million	113,338 Added 2.11%	5,494,591 $323 Million
Q4 2023 Feb 13, 2024	BUY	$37.14 - $64.82 $4.03 Million - $7.03 Million	108,507 Added 2.06%	5,381,253 $322 Million
Q3 2023 Nov 13, 2023	SELL	$23.65 - $89.22 $11.2 Million - $42.4 Million	-474,881 Reduced 8.26%	5,272,746 $201 Million
Q2 2023 Aug 11, 2023	SELL	$76.68 - $93.31 $146 Million - $178 Million	-1,907,824 Reduced 24.92%	5,747,627 $524 Million
Q1 2023 May 12, 2023	SELL	$46.59 - $66.96 $2.27 Million - $3.26 Million	-48,743 Reduced 0.63%	7,655,451 $505 Million
Q4 2022 Feb 13, 2023	BUY	$43.24 - $61.04 $26.7 Million - $37.7 Million	617,864 Added 8.72%	7,704,194 $398 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $12.9 Million - $20 Million	287,786 Added 4.23%	7,086,330 $484 Million
Q2 2022 Aug 12, 2022	BUY	$35.07 - $59.21 $30.7 Million - $51.8 Million	874,624 Added 14.76%	6,798,544 $307 Million
Q1 2022 May 12, 2022	BUY	$35.46 - $54.12 $2.06 Million - $3.15 Million	58,208 Added 0.99%	5,923,920 $301 Million
Q4 2021 Feb 10, 2022	BUY	$30.74 - $49.16 $12.3 Million - $19.6 Million	399,521 Added 7.31%	5,865,712 $277 Million
Q3 2021 Nov 09, 2021	SELL	$31.4 - $69.84 $6.42 Million - $14.3 Million	-204,541 Reduced 3.61%	5,466,191 $180 Million
Q2 2021 Aug 11, 2021	BUY	$40.9 - $64.9 $232 Million - $368 Million	5,670,732 New	5,670,732 $358 Million

Others Institutions Holding APLS

# of Institutions

295

Shares Held

124M

Call Options Held

921K

Put Options Held

761K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.13B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account